Exploring the experiences of hemochromatosis ( HHC ) patients who undergo therapeutic venesection at a blood collection agency
Transfusion · 2025
DOI: 10.1111/trf.18153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Rachel Thorpe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Australian Red Cross Lifeblood, Melbourne, Australia. Hauptthemen laut MEDLINE: Hemochromatosis, Blood Donors, Phlebotomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
People with hereditary hemochromatosis (HHC) require therapeutic phlebotomy on an ongoing basis. Little is known about the facilitators and barriers they experience in donating at a blood collection agency (BCA), nor how these impact their willingness to engage in an ongoing relationship with a BCA. This study explored the experiences of HHC donors undergoing therapeutic phlebotomy at the Australian Red Cross Lifeblood (Lifeblood) in Australia. Study Design and Methods All HHC donors who had made at least one donation at Lifeblood in the last 2 years were invited to complete a survey. In this paper, we report the findings on enablers and barriers to donating at Lifeblood, donor and patient identity, communication, knowledge of blood use and of plasma, interest in donating plasma, and engagement in positive word of mouth about donating.
Results
Data were obtained from 4350 therapeutic donors. Responders identified more enablers than barriers to donating at Lifeblood and 61.8% reported that Lifeblood used their blood. Responders were more likely to identify as donors than patients, and those with a stronger donor than patient identity were significantly more likely to report that their blood was used, had greater interest in donating plasma, and reported engaging in more positive word of mouth about donating.
Discussion
Findings indicate that BCAs can do more to educate donors with HHC about how their blood is used to help others. Doing so may help to retain them as donors and can be beneficial for the blood supply, as well as for the donors themselves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research and Development, Australian Red Cross Lifeblood, Melbourne, Australia.
- Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
- Research and Development, Australian Red Cross Lifeblood, Brisbane, Australia.
- School of Psychology, The University of Queensland, Brisbane, Australia.
- Pathology and Clinical Governance, Australian Red Cross Lifeblood, Perth, Australia.
- Faculty of Health and Medical Sciences, University of WA, Perth, Australia.
ORCID-Profile: Rachel Thorpe, Barbara Masser, Carley N Gemelli
Zitieren
APA
Thorpe, R., Masser, B., Gemelli, C. N., Knight, E., Jos, C., Bentley, P. J., Maddern, J., O'Donovan, J., Kakkos, A., & Welvaert, M. (2025). Exploring the experiences of hemochromatosis ( HHC ) patients who undergo therapeutic venesection at a blood collection agency. Transfusion. https://doi.org/10.1111/trf.18153
Vancouver
Thorpe R, Masser B, Gemelli CN, Knight E, Jos C, Bentley PJ, et al. Exploring the experiences of hemochromatosis ( HHC ) patients who undergo therapeutic venesection at a blood collection agency. Transfusion. 2025. doi:10.1111/trf.18153
BibTeX
@article{Thorpe2025,
author = {Thorpe, Rachel and Masser, Barbara and Gemelli, Carley N and Knight, Elizabeth and Jos, Carol and Bentley, Peter J and Maddern, Jan and O'Donovan, Justine and Kakkos, Athina and Welvaert, Marijke},
title = {Exploring the experiences of hemochromatosis ( HHC ) patients who undergo therapeutic venesection at a blood collection agency},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18153}
}
EUVIMED